Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors.

ABSTRACT:

Introduction

Allogeneic hematopoietic stem cell transplantation (HCT) improves survival of patients with hematologic malignancies. A growing responsibility exists to identify and address long-term morbidity and symptom burden. We investigated metabolic syndrome and symptom burden in adult HCT survivors.

Methods

We analzyed adults with hematologic disorders who were treated with allogeneic HCT at our institution from June 2018-November 2022. We used standard criteria for metabolic syndrome with body mass index (BMI) as a surrogate for waist circumference. We assessed symptom burden using the National Comprehensive Cancer Network Survivorship Assessment. The Short Physical Performance Battery and Short Blessed Test were used to investigate physical function and cognition, resp

SUBMITTER: Trinh JQ 

PROVIDER: S-EPMC11776853 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature